Literature DB >> 9137096

Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines.

R P Negus1, G W Stamp, J Hadley, F R Balkwill.   

Abstract

We have defined the host leukocyte infiltrate in epithelial ovarian tumors and related this to the expression of C-C chemokines. Immunohistochemical analysis of 20 paraffin-embedded biopsies showed that the infiltrate was primarily composed of CD68+ macrophages and CD8+/CD45RO+ T cells (median values, 3700 cells/mm3 and 2200 cells/mm3, respectively). Natural killer cells, B cells, and mast cells occurred in lower numbers (median values, 0 to 200 cells/mm3). Eosinophils were rarely seen and neutrophils were mainly confined to blood vessels. More infiltrating cells were found in stromal than in tumor areas. Only macrophages occurred in significant numbers in areas of necrosis (P < 0.0005). Using in situ hybridization to mRNA, we examined expression of the chemokines MCP-1, MIP-1 alpha, MIP-1 beta, and RANTES. MCP-1 and MIP-1 alpha were expressed by significantly more cells than MIP-1 beta and RANTES (P < 0.005). In tumor epithelial areas, the predominant chemokine was MCP-1. MCP-1 and MIP-1 alpha were the predominant stromal chemokines. A significant correlation was found between the total number of CD8+ T cells and the number of cells expressing MCP-1 (rs = 0.63 and P < 0.003, respectively) and between the CD8+ population and RANTES-expressing cells (rs = 0.6 and P < 0.003). A correlation was also found between CD68+ macrophages and the number of cells expressing MCP-1 (rs = 0.50 and P = 0.026). We suggest that MCP-1 may be responsible for the leukocyte infiltrate in ovarian carcinomas, but the expression of other chemokines may determine its exact nature.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9137096      PMCID: PMC1858213     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes.

Authors:  M Uguccioni; M D'Apuzzo; M Loetscher; B Dewald; M Baggiolini
Journal:  Eur J Immunol       Date:  1995-01       Impact factor: 5.532

2.  Macrophages and metastasis--a biological approach to cancer therapy.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1985-10       Impact factor: 12.701

3.  Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1).

Authors:  E S Kawasaki; M B Ladner; A M Wang; J Van Arsdell; M K Warren; M Y Coyne; V L Schweickart; M T Lee; K J Wilson; A Boosman
Journal:  Science       Date:  1985-10-18       Impact factor: 47.728

4.  Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.

Authors:  I J Fidler; A J Schroit
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

5.  Isolation and characterization of lymphocytes and macrophages from solid, malignant human tumours.

Authors:  J L Svennevig; M Lövik; H Svaar
Journal:  Int J Cancer       Date:  1979-05-15       Impact factor: 7.396

6.  In vitro effects on tumor cells of macrophages isolated from an early-passage chemically-induced murine sarcoma and from its spontaneous metastases.

Authors:  A Mantovani
Journal:  Int J Cancer       Date:  1981-02-15       Impact factor: 7.396

7.  Induction of monocyte migration by recombinant macrophage colony-stimulating factor.

Authors:  J M Wang; J D Griffin; A Rambaldi; Z G Chen; A Mantovani
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

8.  Functional heterogeneity of murine macrophage precursor cells from spleen and bone marrow.

Authors:  M Baccarini; A F Kiderlen; T Decker; M L Lohmann-Matthes
Journal:  Cell Immunol       Date:  1986-09       Impact factor: 4.868

9.  Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms.

Authors:  S E Kabawat; R C Bast; W R Welch; R C Knapp; A K Bhan
Journal:  Int J Cancer       Date:  1983-11-15       Impact factor: 7.396

10.  An immunohistological study of leukocyte localization in benign and malignant breast tissue.

Authors:  K Y Lwin; O Zuccarini; J P Sloane; P C Beverley
Journal:  Int J Cancer       Date:  1985-10-15       Impact factor: 7.396

View more
  99 in total

1.  Weapons ovarian epithelial tumors may use in immune escape: an immunohistochemical correlational study.

Authors:  Eiman Adel Hasby
Journal:  Pathol Oncol Res       Date:  2011-12-08       Impact factor: 3.201

2.  Overexpression of KLF13 and FGFR3 in oral cancer cells.

Authors:  B J Henson; S M Gollin
Journal:  Cytogenet Genome Res       Date:  2010-06-02       Impact factor: 1.636

3.  Alternatively-Activated Macrophages Upregulate Mesothelial Expression of P-Selectin to Enhance Adhesion of Ovarian Cancer Cells.

Authors:  Molly J Carroll; Kaitlin C Fogg; Harin A Patel; Harris B Krause; Anne-Sophie Mancha; Manish S Patankar; Paul S Weisman; Lisa Barroilhet; Pamela K Kreeger
Journal:  Cancer Res       Date:  2018-05-08       Impact factor: 12.701

Review 4.  Tumor-associated macrophages: functional diversity, clinical significance, and open questions.

Authors:  Subhra K Biswas; Paola Allavena; Alberto Mantovani
Journal:  Semin Immunopathol       Date:  2013-05-09       Impact factor: 9.623

5.  Differential association of RANTES-403 and IL-1B-1464 polymorphisms on histological subtypes in male Korean patients with gastric cancer.

Authors:  Juwon Kim; Jong-Won Kim; Yoonjung Kim; Kyung-A Lee
Journal:  Tumour Biol       Date:  2013-12-11

Review 6.  CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis.

Authors:  Jian Zhang; Lalit Patel; Kenneth J Pienta
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-14       Impact factor: 7.638

7.  c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.

Authors:  Xuanmao Jiao; Sanjay Katiyar; Nicole E Willmarth; Manran Liu; Xiaojing Ma; Neal Flomenberg; Michael P Lisanti; Richard G Pestell
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

8.  Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target.

Authors:  Federica Barbieri; Adriana Bajetto; Tullio Florio
Journal:  J Oncol       Date:  2009-12-14       Impact factor: 4.375

Review 9.  Harnessing the effect of adoptively transferred tumor-reactive T cells on endogenous (host-derived) antitumor immunity.

Authors:  Yolanda Nesbeth; Jose R Conejo-Garcia
Journal:  Clin Dev Immunol       Date:  2010-11-07

10.  Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors.

Authors:  Katy Milne; Martin Köbel; Steven E Kalloger; Rebecca O Barnes; Dongxia Gao; C Blake Gilks; Peter H Watson; Brad H Nelson
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.